IE
DWTX

Israel Englander’s Dogwood Therapeutics DWTX Stock Holding History

Israel Englander’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550K Buy
+341,814
New +$566K ﹤0.01% 4717
2021
Q4 		– Sell
-1,151
Closed -$152K – 7476
2021
Q3 		$152K Buy
+1,151
New +$159K ﹤0.01% 6247
2021
Q2 		– Sell
-914
Closed -$131K – 7219
2021
Q1 		$131K Buy
914
+86
+10% +$15K ﹤0.01% 5631
2020
Q4 		$155K Buy
+828
New +$200K ﹤0.01% 4934

Other funds holding DWTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's DWTX Position: Q2 2026 in Review

Israel Englander opened a new position in Dogwood Therapeutics (DWTX) in Q2 2026: 341,814 shares worth $550K. The stake represents ﹤0.01% of the portfolio and ranks #4717 among its holdings. This is a return to the name: Israel Englander previously reported a position in DWTX as recently as Q3 2021.

Israel Englander first reported a position in DWTX in Q4 2020 and has held it in 4 quarters since. 15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • Israel Englander held 341,814 shares of Dogwood Therapeutics worth $550K as of Q2 2026.
  • Dogwood Therapeutics was a new Israel Englander position in Q2 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4717 holding.
  • Israel Englander first reported a position in Dogwood Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.